Please Wait.....
Report
United States Pharmaceutical Warehousing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
Market Report I 2026-02-09 I 150 Pages I Mordor Intelligence
United States Pharmaceutical Warehousing Market Analysis
The United States Pharmaceutical Warehousing Market is expected to grow from USD 2.48 billion in 2025 to USD 2.59 billion in 2026 and is forecast to reach USD 3.24 billion by 2031 at 4.58% CAGR over 2026-2031.
Rising biologics output, full enforcement of the DSCSA serialization rule, and surging e-commerce fulfillment volumes are channeling new capital into temperature-controlled infrastructure and automation. Cell and gene therapy pipelines are adding ultra-low temperature requirements that lift revenue per square foot, while secure track-and-trace systems mandated by 21 CFR 211.142 are reshaping warehouse IT budgets. Cost headwinds energy, real estate and specialized labor remain pronounced, yet continuous investment in robotics, IoT sensors and green cold-chain designs is improving operating leverage. Intensifying consolidation among third-party logistics (3PL) leaders aims to capture higher-margin healthcare contracts and defend share against vertically integrating manufacturers and health-system operators.
United States Pharmaceutical Warehousing Market Trends and Insights
Robust Growth of U.S. Pharmaceutical Output
Annual capital spending of USD 160 billion in 2025 up 15% from 2024 couples every USD 1 billion invested with 2.3 million sq ft of extra warehouse need. Biologics represent 44% of new builds, prompting modular layouts that can flex with continuous-manufacturing schedules. FDA support for Advanced Manufacturing Technologies is accelerating real-time monitoring adoption, pushing facilities to embed redundant power and data systems. Decentralized production of cell therapies is spawning micro-warehouses near treatment centers, eroding the legacy hub-and-spoke network. These shifts collectively lift demand for secure, high-throughput storage nodes across the United States pharmaceutical warehousing market.
Expansion of Temperature-Controlled Storage Needs
Ultra-low requirements from mRNA vaccines (-80 C) to cryogenic therapies (-196 C) are now mainstream, raising energy use 20-30% above ambient operations rules under 21 CFR 600.15 mandate precise ranges, prompting IoT-enabled validations and alarm redundancies. Sustainability targets are spurring reusable shippers that cut fossil-fuel reliance 60%. Operators retrofit high-efficiency compressors and LED lighting to curb consumption, yet capital intensity remains a barrier for smaller entrants. Consequently, cold-chain capacity garners pricing power within the United States pharmaceutical warehousing market.
Stringent FDA cGMP & GDP Compliance Costs
Continuous temperature logging, electronic tracing and quarantine zones add 25% to 2025 compliance budgets. DSCSA serialization systems cost USD 0.5-2 million per facility, stretching small operators; 26% remain non-compliant post-stabilization. Penalties range from fines to criminal liability, accelerating consolidation. Documentation load drives demand for third-party specialists, yet shrinks margins for commodity storage. This regulatory burden dampens the growth curve of the United States pharmaceutical warehousing market.
Other drivers and restraints analyzed in the detailed report include:
Surge in Biologics & Specialty-Drug VolumesRapid B2B/B2C E-commerce Fulfillment RequirementsRising Energy and Real-Estate Costs for Cold Storage
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Distribution and Inventory Management generated 45.32% of 2025 revenue, a testament to long-term contracts that stabilize cash flows within the United States pharmaceutical warehousing market. Value-added offerings-serialization, kitting and regulatory documentation-are scaling at a 5.72% CAGR as DSCSA enforcement tightens. Cloud-based WMS solutions now cover 90% of facilities, enhancing visibility and audit readiness.
Value-added services typically bill 25-40% above baseline rates, offsetting compliance overhead. Robotics-as-a-Service models lower entry barriers for mid-tier operators, supporting market fragmentation while bolstering efficiency. FDA 21 CFR 205.50 stipulates secure storage and handling, favoring providers that can turnkey compliance at scale. These dynamics reinforce storage as the anchor while upgrading service complexity across the United States pharmaceutical warehousing market.
Non-cold-chain sites still constitute 58.05% of the United States pharmaceutical warehousing market size, but cold-chain capacity is outpacing at a 6.01% CAGR through 2031. Chilled, frozen and ultra-low zones command rates 150-200% higher than ambient alternatives, compensating for energy drain.
Operators retrofit ambient structures with modular cool chambers to balance flexibility and capex. IoT sensors cut temperature excursion risk 60%, curbing USD 35 billion annual losses industry-wide temperature mandates create high compliance hurdles, shielding incumbents. As biologics pipelines swell, cold-chain share will progressively rise within the United States pharmaceutical warehousing market.
The United States Pharmaceutical Warehousing Market Report is Segmented by Service Type (Storage, Distribution and Inventory Management, and More), Warehouse Type (Cold-Chain Warehouse, Non-Cold-Chain Warehouse), Product Type (Prescription Drugs, and More), End User (Pharmaceutical Manufacturers, Healthcare Providers, Retail & Pharmacies, and More). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
United Parcel Service Inc. DHL Group FedEx Corp. GEODIS SA CEVA Logistics Lineage Logistics Americold Logistics Cencora BioPharma Logistics Rhenus SE & Co. KG Kuehne + Nagel XPO Logistics KRC Logistics GXO Logistics MD Logistics Langham Logistics Crown LSP Group LifeScience Logistics Go Freight DSV
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 Introduction
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Robust growth of U.S. pharmaceutical output
4.2.2 Expansion of temperature-controlled (2-8 C) storage needs
4.2.3 Surge in biologics and specialty-drug volumes
4.2.4 Rapid B2B/B2C e-commerce fulfillment requirements
4.2.5 DSCSA serialization deadline boosting secure warehousing
4.2.6 Urban micro-fulfillment hubs near key metros
4.3 Market Restraints
4.3.1 Stringent FDA cGMP and GDP compliance costs
4.3.2 Rising energy and real-estate costs for cold storage
4.3.3 Skilled-labor shortages in high-tech warehouses
4.3.4 Escalating cybersecurity / data-integrity risks (under-the-radar)
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape (FDA, DSCSA, DEA, OSHA)
4.6 Technological Outlook (WMS, IoT, Automation, Robotics)
4.7 Porter's Five Forces
4.7.1 Bargaining Power of Suppliers
4.7.2 Bargaining Power of Buyers
4.7.3 Threat of New Entrants
4.7.4 Threat of Substitutes
4.7.5 Intensity of Competitive Rivalry
4.8 Impact of Geopolitics and Pandemic on Warehousing
5 Market Size and Growth Forecasts (Value, USD)
5.1 By Service Type
5.1.1 Storage
5.1.2 Distribution and Inventory Management
5.1.3 Value-added Services and Others
5.2 By Warehouse Type
5.2.1 Cold-Chain Warehouse
5.2.1.1 Chilled (0-5C)
5.2.1.2 Frozen (-18-0C)
5.2.1.3 Ambient
5.2.1.4 Deep-Frozen / Ultra-Low (less than-20 C)
5.2.2 Non-Cold-Chain Warehouse
5.3 By Product Type
5.3.1 Prescription Drugs
5.3.2 OTC Drugs
5.3.3 Biologics and Biosimilars
5.3.4 Vaccines and Blood Products
5.3.5 Clinical Trail Materials
5.3.6 Cell and Gene Therapies
5.3.7 Specialty Medicine (non-biologic)
5.3.8 Veterinary Medicine
5.3.9 Others
5.4 By End User
5.4.1 Pharmaceutical Manufacturers
5.4.2 Healthcare Providers
5.4.3 Retail and Pharmacies
5.4.4 Distributors and Wholesalers
5.4.5 Others
6 Competitive Landscape
6.1 Market Concentration
6.2 Strategic Moves and Investments
6.3 Market Share Analysis
6.4 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
6.4.1 United Parcel Service Inc.
6.4.2 DHL Group
6.4.3 FedEx Corp.
6.4.4 GEODIS SA
6.4.5 CEVA Logistics
6.4.6 Lineage Logistics
6.4.7 Americold Logistics
6.4.8 Cencora
6.4.9 BioPharma Logistics
6.4.10 Rhenus SE & Co. KG
6.4.11 Kuehne + Nagel
6.4.12 XPO Logistics
6.4.13 KRC Logistics
6.4.14 GXO Logistics
6.4.15 MD Logistics
6.4.16 Langham Logistics
6.4.17 Crown LSP Group
6.4.18 LifeScience Logistics
6.4.19 Go Freight
6.4.20 DSV
7 Market Opportunities and Future Outlook
7.1 White-space and Unmet-need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security